Showing results (81-90 of 178) with videos related to
Sort By:
Pageof 18
ACR Open Rheumatology|June 15, 2026
Long-Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus ErythematosusEdward M Vital, Zahir Amoura, Kenneth C Kalunian, et al.The Journal of Rheumatology|December 17, 2011
Association between depression and vascular disease in systemic lupus erythematosusCarol M Greco, Tracy Li, Abdus Sattar, et al.Arthritis and Rheumatism|March 4, 2008
Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosusTrina Thompson, Kim Sutton-Tyrrell, Rachel P Wildman, et al.BMC Medical Genetics|January 13, 2011
Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosusSudeshna Dasgupta, F Yesim Demirci, Amy S Dressen, et al.Annals of the Rheumatic Diseases|February 13, 2025
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trialsEric F Morand, Ronald van Vollenhoven, Richard A Furie, et al.Rheumatology (Oxford, England)|March 17, 2009
Association between depression and coronary artery calcification in women with systemic lupus erythematosusCarol M Greco, Amy H Kao, Abdus Sattar, et al.Journal of Medical Genetics|March 15, 2017
Multiple signals at the extended 8p23 locus are associated with susceptibility to systemic lupus erythematosusF Yesim Demirci, Xingbin Wang, David L Morris, et al.The American Journal of Cardiology|July 6, 2013
Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosusAmy H Kao, Apinya Lertratanakul, Jennifer R Elliott, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 12, 2009
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosusMatthew H Liang, Julia F Simard, Karen Costenbader, et al.Lupus|May 5, 2025
The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysisSusan Manzi, Jorge Sánchez-Guerrero, Naoto Yokogawa, et al.Pageof 18